Related Experiment Video
Updated: May 10, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.1K
Cardio-Oncology and Breast Cancer Therapies
Rohit Singh1,2, Krina Patel3, Haze Xu1,2
1Division of Hematology/Oncology, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Current Treatment Options in Oncology
|April 21, 2025
Summary
Managing breast cancer treatment cardiotoxicity requires pre-treatment cardiac risk assessment, ongoing cardiac function monitoring, and diligent follow-up care to protect patient cardiovascular health.
Area of Science:
- Cardiology
- Oncology
- Cardio-Oncology
Background:
- Breast cancer treatments can lead to cardiotoxicity, impacting patient cardiovascular health.
- Early identification and management of cardiac risks are vital for patient outcomes.
Purpose of the Study:
- To outline essential strategies for managing cardiotoxicity in breast cancer patients.
- To emphasize the importance of cardiovascular evaluation and monitoring throughout treatment.
Main Methods:
- Comprehensive pre-treatment cardiovascular evaluation including history, physical exam, and baseline cardiac imaging.
- Risk stratification to personalize patient management.
- Regular monitoring of cardiac function, including left ventricular ejection fraction (LVEF), during treatment.
Main Results:
- Proactive cardiac risk assessment and monitoring are key to identifying and mitigating cardiotoxicity.
- Timely intervention, including treatment modification, is crucial upon detecting adverse cardiovascular events.
- Long-term follow-up is necessary for survivors to manage potential late cardiac effects.
Conclusions:
- A multidisciplinary approach integrating cardiology and oncology is essential for effective cardiotoxicity management.
- Pre-treatment assessment, continuous monitoring, and structured follow-up are critical components of breast cancer care.
- Optimizing cardiovascular health in breast cancer patients requires ongoing vigilance and personalized strategies.
Related Concept Videos
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:27Tumor Immunotherapy
398
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
398
01:30Cancer Vaccines
238
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
238
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
01:21Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298